RADX

RADIOPHARM THERANOSTICS LTD

RADX·75041J101·US·ADR·Healthcare - Biotechnology-13D/G

RADX (RADIOPHARM THERANOSTICS LTD) is held by 5 institutional investors as of Q2 2026. Largest holders: HSBC HOLDINGS PLC ($253,727), PNC FINANCIAL SERVICES GROUP, INC. ($83,800), UBS Group AG ($6,314). Net institutional sentiment: Bullish.

5
Holders
(1 Elite)
$350,147
Total Value
80% (5)
Consensus
4 buying - 1 selling
13F: Insider & Congress: Updated regularly
RADX

Smart Money Verdict

View all
Loading verdict
Held by 5 funds
1 elite

Who's Trading

Source dates: Price Sep 21, 2026 · Insiders none · Activists Jan 8, 2026 · Congress none

ActivistRPRegal Partners Holdings Pty Limited9.1%Jan 8, 2026

Top Holders

Checking access…
Action
Increased
62,188(+1.3%)$253,7270.0%-70.47%
23
Increased
20,000(+25.0%)$83,8000.0%-69.88%
18
Decreased
1,507(-49.8%)$6,3140.0%-67.98%
0
New
1,310$5,4890.0%-63.72%
23
Increased
195(+61.2%)$8170.0%-67.06%
11
RADXRADXRADIOPHARM THERANOSTICS LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used